Crestline Management, LP Baxter International Inc Transaction History

Crestline Management, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$76.85 - $89.45 $6.57 Million - $7.65 Million	-85,496 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$74.57 - $87.19 $2 Million - $2.34 Million	26,796 Added 45.65%	85,496 $7.34 Million
Q3 2021 Nov 12, 2021	BUY	$73.77 - $83.61 $4.33 Million - $4.91 Million	58,700 New	58,700 $4.72 Million
Q3 2018 Nov 14, 2018	SELL	$70.71 - $77.75 $3.69 Million - $4.05 Million	-52,154 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$63.43 - $75.41 $3.31 Million - $3.93 Million	52,154 New	52,154 $3.85 Million

989

448M

2.22M

3.04M

Ticker BAX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 504,120,992
Market Cap $18.1B
Description
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...

Get notified when there are updates to the investment portfolio of Crestline Management, LP, based on Form 13F filings with the SEC.

Stay updated on Crestline Management, LP with notifications on news.